Embryologie und Teratologie

  • W.E. Paulus
Chapter

Zusammenfassung

Inwieweit sich aus einer Zygote ein unauffälliges Neugeborenes entwickelt, hängt von vielen endogenen und exogenen Faktoren ab: Zu den endogenen Faktoren zählen insbesondere die genetische Ausstattung und der mütterliche Gesundheitszustand, zu den exogenen Faktoren Infektionen, Strahlung, Umweltschadstoffe, Medikamente und Drogen.

This is a preview of subscription content, log in to check access.

Literatur

  1. ACOG (1994) Substance abuse in pregnancy. ACOG Tech Bull No 195. Int J Gynaecol Obstet 47: 73–80CrossRefGoogle Scholar
  2. ACOG (1997) Teratology. ACOG Educ Bull No 236. Int J Gynaecol Obstet 57: 319–326CrossRefGoogle Scholar
  3. ACOG (2003) Immunization during pregnancy. ACOG Committee Opinion No. 282. Obstet Gynecol 101: 207–212CrossRefGoogle Scholar
  4. ACOG Committee on Obstetric Practice (2004) ACOG Committee Opinion Number 299. Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol 104: 647–51CrossRefGoogle Scholar
  5. ACOG Committee on Practice Bulletins (2005) Clinical management guidelines for obstetrician-gynecologists. Pregestational diabetes mellitus. Obstet Gynecol 105: 675–685CrossRefGoogle Scholar
  6. Ad Hoc Committee of the Scientific Assembly on Microbiology, Tuberculosis and Pulmonary Infections (1995) Treatment of tuberculosis and tuberculosis infection in adults and children. Clin Infect Dis 21: 9–27CrossRefGoogle Scholar
  7. Alwan S, Friedman JM (2009) Safety of selective serotonin reuptake inhibitors in pregnancy. CNS Drugs 23: 493–509PubMedCrossRefGoogle Scholar
  8. Andrade et al. (2009) Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 18: 246–52Google Scholar
  9. Antiretrovir Pregnancy Registry Steering Committee (2007) Antiretrovir Pregnancy Registry Interim Report for 1 January 1989 through 31 Juli 2007. WilmingtonGoogle Scholar
  10. Briggs GG, Freeman RK, Yaffe S (2008) Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 8th edn. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  11. Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G (1995) Safety of metronidazole in pregnancy: a meta-analysis. Am J Obset Gynecol 172: 525–529CrossRefGoogle Scholar
  12. Clarren SK (1981) Recognition of fetal alcohol syndrome. JAMA 245: 2436–2439PubMedCrossRefGoogle Scholar
  13. Costedoat-Chalumeau N, Amoura Z, Duhaut P, Huong du LT, Sebbough D, Wechsler B, Vauthier D, Denjoy I, Lupoglazoff JM, Piette JC (2003) Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum 48: 3207–11PubMedCrossRefGoogle Scholar
  14. Degenhardt KH (1971) Pränatale Pathologie: Definition, Häufigkeit, Ätiologie und Pathogenese von Mißbildungen. In: Opitz H (Hrsg) Handbuch der Kinderheilkunde, Bd I/1. Springer, Berlin Heidelberg New York, S 602–624Google Scholar
  15. DFG – Deutsche Forschungsgemeinschaft (2006) Maximale Arbeitsplatzkonzentrationen und biologische Arbeitsstofftoleranzwerte. VCH, WeinheimGoogle Scholar
  16. Diav-Citrin O, Ornoy A (2002) Teratogen update: antithyroid drugsmethimazole, carbimazole, and propylthiouracil. Teratology 65: 38PubMedCrossRefGoogle Scholar
  17. Enders G (1991) Infektionen und Impfungen in der Schwangerschaft, 2. Aufl. Urban & Schwarzenberg, MünchenGoogle Scholar
  18. Fried PA, Watkinson B (1990) 36- and 48-month neurobehavioral follow- up of children prenatally exposed to marijuana, cigarettes and alcohol. Dev Behav Pediatr 11: 49–58CrossRefGoogle Scholar
  19. Fried S, Kozer E, Nulman I, Einarson TR, Koren G (2004) Malformation rates in children of women with untreated epilepsy: a meta-analysis. Drug Saf 27: 197–202PubMedCrossRefGoogle Scholar
  20. Gonzalez CH, Marques-Dias MJ, Kim CA (1998) Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet 351: 1624–1627PubMedCrossRefGoogle Scholar
  21. Harden et al. (2009a) Practice parameter update: management issues for women with epilepsy–focus on pregnancy (an evidencebased review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 73:133–141Google Scholar
  22. Harden et al. (2009b) Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidencebased review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 73:142–149Google Scholar
  23. Jacobson SJ, Jones K, Johnson K (1992) Prospective multicenter study of pregnancy outcome after lithium exposure during first trimester. Lancet 339: 530–533PubMedCrossRefGoogle Scholar
  24. Jamieson DJ et al, Novel Influenza A (H1N1) Pregnancy Working Group (2009) H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 374: 451–458PubMedCrossRefGoogle Scholar
  25. Jones K (1974) Outcome in offspring of chronic alcoholic women. Lancet i: 1076–1078Google Scholar
  26. Kallen BA, Otterblad Olausson P (2007) Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol 79: 301–308PubMedCrossRefGoogle Scholar
  27. Kalter H, Warkany J (1983) Congenital malformations. N Engl J Med 308: 491–497PubMedCrossRefGoogle Scholar
  28. Keller F, Griesshammer M, Haussler U, Paulus W, Schwarz A (2001) Pregnancy and renal failure: the case for application of dosage guidelines. Drugs 61: 1901–1920PubMedCrossRefGoogle Scholar
  29. Knörr K, Knörr-Gärtner H, Beller FK, Lauritzen C (1989) Geburtshilfe und Gynäkologie. Physiologie und Pathologie der Reproduktion, 3. Aufl. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  30. Koren G (1994) Maternal-fetal toxicology – a clinician’s guide, 2nd edn. Marcel Dekker, New YorkGoogle Scholar
  31. Lamotrigine Pregnancy Registry. Interim Report. September 1992 through 30 September 2007. Wilmington NC, January 2008Google Scholar
  32. Lennestål R, Källén B (2007) Delivery outcome in relation to maternal use of some recently introduced antidepressants. J Clin Psychopharmacol 27: 607–613PubMedCrossRefGoogle Scholar
  33. McElhatton PR, Bateman DN, Evans C, Pughe KR, Thomas SHL (1999) Congenital anomalies after prenatal ecstasy exposure. Lancet 154: 1441–1442CrossRefGoogle Scholar
  34. McElhatton PR, Garbis HM, Elefant E, Vial T, Bellemin B, Serafini MA, Arnon J, Rodriguez-Pinilla E, Schaefer C, Pexieder T, Merlob P, dal Verme S (1996) The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. Reprod Toxicol 10: 285–294PubMedCrossRefGoogle Scholar
  35. Merlob P, Stahl B, Klinger G (2009) Tetrada of the possible mycophenolate mofetil embryopathy: a review. Reprod Toxicol 28: 105–158PubMedCrossRefGoogle Scholar
  36. Moretti ME, Bar-Oz B, Fried S, Koren G (2005) Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology 16: 216–219PubMedCrossRefGoogle Scholar
  37. Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, Irwin B, McGivern RC, Morrison PJ, Craig J (2006) Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK epilepsy and preg-nancy register. J Neurol Neurosurg Psychiat 77: 193–198PubMedCentralPubMedCrossRefGoogle Scholar
  38. Nulman I, Rovet J, Stewart DE, Wolpin J, Gardner HA, Theis JGW, Kulin N, Koren G (1997) Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 336: 258–262PubMedCrossRefGoogle Scholar
  39. Oren D, Nulman I, Makhija M, Ito S, Koren G (2004) Using corticosteroids during pregnancy. Are topical, inhaled, or systemic agents associated with risk? Can Fam Physician 50: 1083–1085PubMedCentralPubMedGoogle Scholar
  40. Ornoy A (2009) Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Reprod Toxicol 28: 1–10PubMedCrossRefGoogle Scholar
  41. Paulus WE, Lauritzen C (2009) Medikamente und Schadstoffe in Schwangerschaft und Stillzeit. 10. Aktualisierung. Spitta, BalingenGoogle Scholar
  42. Pursley TJ, Blomquist IK, Abraham J, Andersen HF, Bartley JA (1996) Fluconazole-induced congenital anomalies in three infants. CID 22: 336–340CrossRefGoogle Scholar
  43. Rösch C, Steinbicker V (2003) Aetiology of congenital malformations – analysis of malformation registry data compared with the Kalter & Warkany study. Reprod Toxicol 17: 503–504Google Scholar
  44. Shepard TH, Brent RL, Friedman JM, Jones KL, Miller RK, Moore CA, Polifka JE (2002) Update on new developments in the study of human teratogens. Teratology 65:153–161PubMedCrossRefGoogle Scholar
  45. Steinhausen HC, Willms J, Spohr HL (1995) Die Berliner Verlaufsstudie von Kindern mit einem Fetalen Alkoholsyndrom (FAS). 2. Psychiatrische und psychologische Befunde. Monatsschr Kinderheilkd 143: 157–164Google Scholar
  46. Streissguth AP, Aase JM, Clarren SK, Randels SP, La Due RA, Smith DF (1991) Fetal alcohol syndrome in adolescents and adults. JAMA 265: 1961–1967PubMedCrossRefGoogle Scholar
  47. Streissguth AP, Barr HM, Sampson PD (1990) Moderate prenatal alcohol exposure: effects on child IQ and learning problems at age 7 1/2 years. Alcohol Clin Exp Res 14: 662–669PubMedCrossRefGoogle Scholar
  48. van Driel D, Wesseling J, Sauer PJ, Touwen BC, van der Veer E, Heymans HS (2002) Teratogen update: fetal effects after in utero exposure to coumarins overview of cases, follow-up findings, and pathogenesis. Teratology 66: 127–140PubMedCrossRefGoogle Scholar
  49. Werler MM (1997) Teratogen update: smoking and reproductive outcomes. Teratology 55: 382–388PubMedCrossRefGoogle Scholar
  50. Wilson JD (1977) Embryotoxicity of drugs to man. In: Wilson JD, Frazer FC Handbook of teratology. Plenum, New York, pp 309–355Google Scholar
  51. Yacobi S, Ornoy A (2008) Is lithium a real teratogen? What can we conclude from the prospective versus retrospective studies? A review. Isr J Psychiat Relat Sci. 45: 95–106Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • W.E. Paulus
    • 1
  1. 1.Krankenhaus St. ElisabethInst. für ReproduktionstoxikologieRavensburg

Personalised recommendations